Tagrisso 80 mg Tablet
  1. Home
  2. Pharma Products
  3. AstraZeneca Pharma India Ltd
  4. Tagrisso 80 mg Tablet

Tagrisso 80 mg Tablet

Tagrisso 80 mg Tablet contains osimertinib, a targeted anticancer medicine used to treat certain types of non-small cell lung cancer. Each tablet contains 80 mg of osimertinib and is taken orally as prescribed by a specialist. It targets specific EGFR mutations that can drive the growth of lung cancer cells.

BUY NOW

Category

Osimertinib is an EGFR tyrosine kinase inhibitor designed to block abnormal EGFR signaling in cancer cells. It is used for eligible patients with specific EGFR mutations, including exon 19 deletions and exon 21 L858R mutations, and in certain T790M-positive cases. Tagrisso may be used as adjuvant therapy after tumor removal or for locally advanced or metastatic non-small cell lung cancer according to the clinical indication. Treatment requires specialist supervision and monitoring for potential adverse effects.

Technical Specification

Specification Details
Active Ingredient Osimertinib
Strength 80 mg
Dosage Form Film-Coated Tablet
Route of Administration Oral
Pack Size 30 Tablets
Manufacturer AstraZeneca

Product Also Known As

Tagrisso 80 mg Tablet, Osimertinib 80 mg Tablet, Osimertinib Mesylate 80 mg Tablet, Tagrisso Osimertinib Tablet, EGFR Inhibitor Tablet, Non-Small Cell Lung Cancer Treatment Tablet

Related products